Conferences on December 04, 2018

The ninth annual Argus European LPG Markets conference is your opportunity to explore the key drivers for LPG growth, identify supply and demand trends, and learn about new advancements in synthetic LPG, while networking with existing contacts and establishing new business relationships. Book now to join key stakeholders from across the supply chain, including distributors, traders, regional associations, integrated companies, petrochemical producers, as well as logistics and service providers. The notable speaker line-up includes: - Can Toydemir, Operations Director, - Tom Carlisle, Gas Analyst, Gibson - Christoph Reimnitz, Global Structuring Leader Gas to Power/Project Development, GE - Peter Westwood, Chief Executive, - Adam Thompson, Operations ...

Optimise drilling and production operations with digital technologies. Operator led case studies exploring how they have launched, refined and grown digital projects will allow you to take away practical information on how you too can launch or adapt your current activities to increase efficiency and reduce risk using digital technologies and data analytics. Senior representatives from operators of all sizes - from Equinor to Alpha Petroleum - are scheduled to present case studies and live demonstrations from their digital programmes. Get digital transformation projects - Hear how to obtain the budget and get the go ahead to launch digital Operator case studies on where they have found digital - Hear the journey of digital optimisation projects, the challenges ...

The 3rd Digital Pharma Multichannel Marketing Boot Camp East uses a combination of lectures, class discussions and hands-on exercises with people who want to understand how to create effective and sophisticated digital and multichannel marketing (MCM) strategies. This intensive, two-day program teaches you strategic processes and gives you the tools and skills you need to gather insights and develop your own digital and multichannel programs. By attending, you will discover the roles each digital channel does best in advancing your objectives, as well as how to bring them together into an integrated plan.

With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up. As such, I wanted to introduce to you to the 1st RNA-Targeted Drug Discovery Summit 2018 (Boston, MA - December 3-6, 2018) - a niche scientific and networking forum, carefully curated from those at large pharma, biotech and academia who are pioneering the next generation of small molecule drug discovery. The 1st RNA-Targeted Drug Discovery Summit will bring together a unique community of experts, devoted to optimizing the process of discovering and designing small molecules that bind specifically to quality RNA targets and translating these into clinically safe and effective therapies. Sounds interesting? Get your free event ...

Accelerate the Adoption of True IPD & IPD Learn from Leading Owners, Designers, & Advancing Integrated Project Delivery is the only event focused on accelerating True IPD and IPD Lite adoption. Our mission is to enable contractors, design firms and clients to work more collaboratively through best practices in contractual incentives, team culture and workflow. We believe IPD is the future. Join us to be part of it. This is your chance to focus on critical questions around the risk, rewards, setup and execution of IPD projects through the lens of owners, contractors, design firms and trades. For those looking to begin your IPD journey, workshops and case studies will explore the first steps you need to take, as well as alert you to common lessons learned. For ...

Through case studies, interactive sessions, and focused presentations, this year's conference will explore content development strategies, along with optimal ways to create and distribute content across multiple channels. Join the industry’s foremost content marketing experts at the 7th Content Marketing for Life Sciences conference as professionals explore how to deliver a more integrated customer experience by connecting content, channels and analytics within your marketing strategy. Our speaking faculty will address an array of timely issues to help you better deliver the right content to the right person at the right time.

Up to 35 AMA PRA Category 1 Credits™ Up to 7 AMA PRA Category 1 Credits™ each day This year we offer up to 28 SAMs; Prepare for Maintenance of Certification (MOC) including a wide range of topics for Clinical Content SAMs. Multi-day Clinical Pathways in Abdominal, Chest including Cardio, Emergency, Genitourinary, Neurology and Musculoskeletal. Dedicated Breast Imaging track including breast workshops. New - Nuclear Medicine for the Community Radiologist session. This conference is suitable for radiologists

As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy. This year we will be incorporating commercial insights from companies such as Merck, Virogen, Sagetis, Lokon Pharma, Replimmune, Western Oncolytics, DNAtrix and many more, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that ...

HERE you meet the experts from Europe, America and Asia! • Extensive OEM reports • Delegates from from 25 countries • Most international* industry meeting in Europe (* over 35% participants from non-German speaking countries) • 2,700 participants in USA, China & Europe in 2017

ABOUT THE EVENT: The PREDiCT Conference Series is dedicated to exploring the latest advances in the application of preclinical models to help us fail faster and get better disease modifying therapies from bench to patient. Tumour Models London sits at the interface of innovation in model development and therapeutic application. For the last 7 years it has, and will continue to, bring together a multidisciplinary mix of model developers, translational and pharmacology research scientists to debate how these tools should be further adapted to add immediate value to oncology and IO programmes. WHY ATTEND? Merging its unique strategic focus and scientific quality of presentations, the event facilitates an environment of knowledge sharing and debate. Where other conferences require you sit ...